Rockefeller Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.8K Buy
771
+192
+33% +$26.8K ﹤0.01% 2934
2025
Q4
$94.9K Buy
579
+387
+202% +$60.6K ﹤0.01% 2750
2025
Q3
$25.7K Buy
+192
New +$23.3K ﹤0.01% 3230
2023
Q1
Sell
-859
Closed -$145K 3489
2022
Q4
$145K Sell
859
-1
-0.1% -$181 ﹤0.01% 1826
2022
Q3
$160K Buy
860
+753
+704% +$159K ﹤0.01% 1748
2022
Q2
$17K Buy
107
+31
+41% +$4.9K ﹤0.01% 2839
2022
Q1
$14K Buy
76
+29
+62% +$5.51K ﹤0.01% 2894
2021
Q4
$12K Sell
47
-67
-59% -$18.1K ﹤0.01% 2897
2021
Q3
$32K Buy
114
+11
+11% +$2.82K ﹤0.01% 2364
2021
Q2
$20K Sell
103
-48
-32% -$9.31K ﹤0.01% 2492
2021
Q1
$29K Sell
151
-26
-15% -$5.33K ﹤0.01% 2119
2020
Q4
$33K Buy
177
+102
+136% +$18.6K ﹤0.01% 1826
2020
Q3
$11K Buy
+75
New +$10.7K ﹤0.01% 1990

Other funds holding RGEN

Rockefeller Capital Management's RGEN Position: Q1 2026 in Review

Rockefeller Capital Management increased its Repligen (RGEN) stake by 33% in Q1 2026, buying an estimated $26.8K and bringing the position to 771 shares worth $90.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2934.

Rockefeller Capital Management first reported a position in RGEN in Q3 2020 and has held it in 13 quarters since. The position peaked at $160K in Q3 2022. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Rockefeller Capital Management held 771 shares of Repligen worth $90.8K as of Q1 2026.
  • Rockefeller Capital Management bought 192 Repligen shares in Q1 2026, an estimated $26.8K.
  • Repligen made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2934 holding.
  • Rockefeller Capital Management first reported a position in Repligen in Q3 2020 and has held it in 13 quarters since.
  • Rockefeller Capital Management's Repligen position peaked at $160K in Q3 2022.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.